home / stock / vyne / vyne short
Short Information | VYNE Therapeutics Inc Com (NASDAQ:VYNE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 140,202 |
Total Actual Volume | 1,188,727 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 7,010 |
Average Short Percentage | 15.77% |
Is there a VYNE Short Squeeze or Breakout about to happen?
See the VYNE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-03-2024 | $2.54 | $2.62 | $2.7682 | $2.53 | 34,681 | 6,988 | 20.15% |
05-02-2024 | $2.53 | $2.5 | $2.53 | $2.4 | 29,242 | 1,140 | 3.9% |
05-01-2024 | $2.5 | $2.53 | $2.57 | $2.5 | 83,587 | 3,191 | 3.82% |
04-30-2024 | $2.61 | $2.52 | $2.61 | $2.4 | 39,454 | 1,658 | 4.2% |
04-29-2024 | $2.54 | $2.63 | $2.63 | $2.5303 | 19,253 | 2,901 | 15.07% |
04-26-2024 | $2.53 | $2.5 | $2.5752 | $2.42 | 15,899 | 803 | 5.05% |
04-25-2024 | $2.52 | $2.47 | $2.8 | $2.41 | 77,467 | 4,428 | 5.72% |
04-24-2024 | $2.4 | $2.57 | $2.7305 | $2.295 | 384,452 | 12,634 | 3.29% |
04-23-2024 | $2.31 | $2.32 | $2.36 | $2.2401 | 30,168 | 4,555 | 15.1% |
04-22-2024 | $2.24 | $2.35 | $2.43 | $2.24 | 27,675 | 5,934 | 21.44% |
04-19-2024 | $2.26 | $2.25 | $2.34 | $2.25 | 18,999 | 1,844 | 9.71% |
04-18-2024 | $2.39 | $2.3 | $2.39 | $2.25 | 11,098 | 2,879 | 25.94% |
04-17-2024 | $2.3327 | $2.4 | $2.5 | $2.3327 | 31,265 | 3,624 | 11.59% |
04-16-2024 | $2.5 | $2.42 | $2.5 | $2.38 | 33,106 | 11,373 | 34.35% |
04-15-2024 | $2.85 | $2.57 | $2.85 | $2.43 | 58,530 | 6,162 | 10.53% |
04-12-2024 | $2.93 | $2.77 | $2.93 | $2.6879 | 28,561 | 8,218 | 28.77% |
04-11-2024 | $2.67 | $3 | $3.0199 | $2.56 | 104,623 | 32,663 | 31.22% |
04-10-2024 | $2.7 | $2.68 | $2.84 | $2.55 | 60,847 | 6,115 | 10.05% |
04-09-2024 | $2.755 | $2.76 | $2.8 | $2.69 | 28,419 | 10,958 | 38.56% |
04-08-2024 | $2.78 | $2.74 | $2.8161 | $2.65 | 71,401 | 12,134 | 16.99% |
News, Short Squeeze, Breakout and More Instantly...
VYNE Therapeutics Inc Com Company Name:
VYNE Stock Symbol:
NASDAQ Market:
Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligo BRIDGEWATER, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage ...
BRIDGEWATER, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inf...
2023 was a transformative year for VYNE, marked by the achievement of clinical proof-of-concept for VYN201 in vitiligo and a successful financing with a syndicate of leading institutional investors Anticipate commencing a Phase 2b trial for VYN201 and a Phase 1a trial for VYN202 in Q...